Shandong Sinobioway Biomedicine Co., Ltd. announced earnings results for the half year ended June 30, 2020. For the half year, the company announced sales was CNY 135.955 million compared to CNY 299.601 million a year ago. Operating loss was CNY 102.271 million compared to operating Income of CNY 35.111 million a year ago. Net loss was CNY 92.352 million compared to net income of CNY 25.655 million a year ago. Basic loss per share from continuing operations was CNY 0.14 compared to basic earnings per share from continuing operations of CNY 0.0389 a year ago.